AIC
BIO icon

Ameritas Investment Company’s Bio-Rad Laboratories Class A BIO Stock Holding History

Ameritas Investment Company’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-968
Closed -$553K – 868
2021
Q1 		$553K Buy
+968
New +$573K 0.05% 332
2019
Q1 		– Sell
-35
Closed -$8K – 1060
2018
Q4 		$8K Buy
+35
New +$9.39K ﹤0.01% 1107

Other funds holding BIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Ameritas Investment Company's BIO Position: Q2 2021 in Review

Ameritas Investment Company sold out of Bio-Rad Laboratories Class A (BIO) in Q2 2021, closing a stake of 968 shares — an estimated $553K sold.

Ameritas Investment Company first reported a position in BIO in Q4 2018 and held it in 2 quarters. The position peaked at $553K in Q1 2021. 509 funds tracked by Wall St. Rank hold BIO as of Q2 2021.

  • Ameritas Investment Company reported no remaining Bio-Rad Laboratories Class A position as of Q2 2021 after selling out during the quarter.
  • Ameritas Investment Company sold 968 Bio-Rad Laboratories Class A shares in Q2 2021, an estimated $553K.
  • Ameritas Investment Company first reported a position in Bio-Rad Laboratories Class A in Q4 2018 and held it in 2 quarters.
  • Ameritas Investment Company's Bio-Rad Laboratories Class A position peaked at $553K in Q1 2021.
  • 509 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2021.

Based on Ameritas Investment Company's 13F filing for Q2 2021, filed 16 Aug 2021.